Trademark: 90072154
Word
ARGONAUT THERAPEUTICS
Status Date
Tuesday, December 28, 2021
Registration Number
6600091
Registration Date
Tuesday, December 28, 2021
Filing Date
Friday, July 24, 2020
Published for Opposition
Tuesday, October 12, 2021
5 Epigenetic drugs for the treatment, diagnosis, detection and prevention of cancer; epigenetic drugs targeting arginine methylation in cancer; pharmaceutical preparations in the nature of inhibitors of arginine methylation for the treatment of cancer; pharmaceutical preparations in the nature of inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of cancer; cancer treatment vaccines; therapeutic vaccines for treating cancer; cancer therapy subsection vaccines; pharmaceutical compounds for the treatment, diagnosis, detection and prevention of cancer; pharmaceutical products, preparations and substances for the treatment, diagnosis, detection and prevention of cancer; biological preparations and substances for the treatment, diagnosis, detection and prevention of cancer
42 Research and development services in the pharmaceutical and biotechnology fields; medical research and development services in the pharmaceutical and biotechnology fields; scientific research and development services; pharmaceutical research and development services; research and development in the field of epigenetic drugs for the treatment, diagnosis, detection and prevention of cancer; research and development in the field of epigenetic drugs targeting arginine methylation in cancer; research and development in the field of inhibitors of arginine methylation for the treatment of cancer; research and development in the field of inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of cancer; research and development in the field of cancer treatment vaccines, therapeutic vaccines for treating cancer and cancer therapy subsection vaccines; research and development in the field of compounds for the treatment, diagnosis, detection and prevention of cancer; research and development in the field of pharmaceutical products, preparations and substances for the treatment, diagnosis, detection and prevention of cancer; research and development in the field of biological preparations and substances for the treatment, diagnosis, detection and prevention of cancer; consultancy, advisory and information services relating to and connected with the aforementioned services
Dec 28, 2021
Registered-Principal Register
Oct 12, 2021
Official Gazette Publication Confirmation E-Mailed
Oct 12, 2021
Published For Opposition
Sep 22, 2021
Notification Of Notice Of Publication E-Mailed
Sep 3, 2021
Law Office Publication Review Completed
Sep 3, 2021
Approved For Pub - Principal Register
Sep 3, 2021
Examiner's Amendment Entered
Sep 3, 2021
Notification Of Examiners Amendment E-Mailed
Sep 3, 2021
Examiners Amendment E-Mailed
Sep 3, 2021
Examiners Amendment -Written
Aug 12, 2021
Assigned To Examiner
Jul 7, 2021
Teas/Email Correspondence Entered
Jul 7, 2021
Correspondence Received In Law Office
Jul 7, 2021
Assigned To Lie
May 17, 2021
Teas Response To Office Action Received
Nov 17, 2020
Notification Of Non-Final Action E-Mailed
Nov 17, 2020
Non-Final Action E-Mailed
Nov 17, 2020
Non-Final Action Written
Nov 10, 2020
Assigned To Examiner
Aug 21, 2020
New Application Office Supplied Data Entered In Tram
Jul 28, 2020
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
